About clot management devices
A blood clot or thrombus is the end stage of blood coagulation process in hemostasis. Blood clot is the body's response to an injury to prevent bleeding. However, a clot can be harmful when it forms abnormally to obstruct blood flow through healthy blood vessels. This condition is called thrombosis. A blood clot in arteries can lead to heart attack, while blood clot formed in the deep veins can lead to DVT or PE. Clot management devices help in the removal of a clot or dissolving clot in the blood vessels.
Global clot management devices market to grow at a CAGR of 5.95 percent over the period 2014-2019.
Read more details @ http://www.bigmarketresearch.com/global-clot-management-devices-2015-2019-market
Covered in this report
The report covers the present scenario and the growth prospects of the global clot management devices market for the period 2015-2019. Based on type of devices, the market can be segmented as follows: percutaneous thrombectomy devices, embolectomy balloon catheters, catheter-directed thrombolysis, IVCF, and neurovascular embolectomy devices.
Global Clot Management Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the APAC and EMEA; it also covers the global clot management devices market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
• Boston Scientific
• Cook Group
Other prominent vendors
• Argon Medical Devices
• Asid Bonz
• Biosensors International Group
• Control Medical Technology
• DePuy Synthes
• Growing awareness of endovascular treatment
• For a full, detailed list, view our report
• Acceptance of...